Introduction: Polycystic ovary syndrome (PCOS) is a common hormonal disorder among young women, correlated with hyperandrogenism. Among the symptoms of PCOS, vocal alterations are quite unknown. Dysphonia may be related to hyperandrogenism, and there is no consensus about its prevalence and the severity of vocal disorders, which can cause noticeable discomfort. Methods: A systematic review of the literature was conducted. Four studies on PCOS that evaluated the phonatory system were included for a total of 174 patients (96 PCOS, 78 controls), and a meta-analysis on comparable data was performed. Results: Four studies evaluated parameters related to vocal symptomatology, altered audiometric examination, and findings at the laryngoscopy in patients affected by PCOS versus controls. Although the individual studies showed increased incidence of alterations and a tendency to develop speech fatigue in women with PCOS, when the results of studies were pulled in meta-analysis, the overall difference was not statistically significant. The studies themselves were very different from each other; therefore, it is hard to draw any firm conclusions. Discussion: The aim of this study was to assess the prevalence of vocal alterations, the correlation with hyperandrogenism, the quality of life, and the voice changes after starting a therapy for PCOS. The present meta-analysis failed to find any difference in terms of PCOS and control cohort. However, the lack of high-quality studies makes it difficult to draw firm conclusions. New and larger studies or big population program data are therefore warranted.

Polycystic ovary syndrome (PCOS) is characterized by endocrine dysfunctions, including insulin resistance and hyperandrogenism, in addition to the typical ultrasound appearance of the ovaries with many small follicles. PCOS can manifest itself with weight gain, infertility, menstrual irregularities, alopecia, hirsutism, acne. Among the less known aspects of such syndrome affecting young women, there is the vocal change, which can be accompanied with discomfort, decreased tone of voice, and, in some cases, sore throat. This article analyzes the literature with a systematic review to understand how PCOS is related to vocal changes. Works that have been included analyse symptoms, hormonal values, and acoustic parameters to identify differences between the general population and the population affected by PCOS and to describe possible connections.

2.
Guzick
D
.
Polycystic ovary syndrome: symptomatology, pathophysiology, and epidemiology
.
Am J Obstet Gynecol
.
1998
;
179
(
6 Pt 2
):
S89
93
. .
3.
Gugatschka
M
,
Lichtenwagner
S
,
Schwetz
V
,
Lerchbaum
E
,
Graupp
M
,
Gerstenberger
C
, et al
.
Subjective and objective vocal parameters in women with polycystic ovary syndrome
.
J Voice
.
2013
;
27
(
1
):
98
100
. .
4.
Aydin
K
,
Akbulut
S
,
Demir
MG
,
Demir
S
,
Ozderya
A
,
Temizkan
S
, et al
.
Voice characteristics associated with polycystic ovary syndrome
.
Laryngoscope
.
2016
;
126
(
9
):
2067
72
. .
5.
Hannoun
A
,
Zreik
T
,
Husseini
ST
,
Mahfoud
L
,
Sibai
A
,
Hamdan
AL
.
Vocal changes in patients with polycystic ovary syndrome
.
J Voice
.
2011
;
25
(
4
):
501
4
. .
6.
Blahayil
S
,
Gunjawate
DR
,
Balasubramanium
RK
.
Kymographic characteristics of voice in women with Polycystic ovary syndrome
.
Codas
.
2021
;
33
(
5
):
e20200128
. .
7.
Page
MJ
,
McKenzie
JE
,
Bossuyt
PM
,
Boutron
I
,
Hoffmann
TC
,
Mulrow
CD
, et al
.
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
.
PLoS Med
.
2021
;
18
(
3
):
e1003583
. .
8.
Sterne
JAC
,
Hernán
MA
,
Reeves
BC
,
Savović
J
,
Berkman
ND
,
Viswanathan
M
, et al
.
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
.
Br Med J
.
2016
;
355
:
i4919
. .
9.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
.
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
.
Fertil Steril
.
2004
;
81
(
1
):
19
25
. .
10.
Colizza
A
,
Ralli
M
,
Cavalcanti
L
,
Cambria
F
,
Greco
A
,
de Vincentiis
M
.
Voice quality analysis of reinke's edema according to recent new classification
.
J Voice
.
2022
;
S0892-1997(22):00142-4
. .
11.
Colizza
A
,
Ralli
M
,
Di Stadio
A
,
Cambria
F
,
Zoccali
F
,
Cialente
F
, et al
.
Outcomes of laryngeal cancer surgery after open partial horizontal laryngectomies with lateral cervical approach
.
J Clin Med
.
2022
;
11
(
16
):
4741
. .
12.
Colizza
A
,
Ralli
M
,
D’Elia
C
,
Greco
A
,
de Vincentiis
M
.
Voice quality after transoral CO2 laser microsurgery (TOLMS): systematic review of literature
.
Eur Arch Oto-Rhino-Laryngol
.
2022
;
279
(
9
):
4247
55
. .
13.
Zamponi
V
,
Mazzilli
R
,
Mazzilli
F
,
Fantini
M
.
Effect of sex hormones on human voice physiology: from childhood to senescence
.
Hormones
.
2021
;
20
(
4
):
691
6
. .
14.
Bowling
DL
,
Dunn
JC
,
Smaers
JB
,
Garcia
M
,
Sato
A
,
Hantke
G
, et al
.
Rapid evolution of the primate larynx
.
PLoS Biol
.
2020
;
18
(
8
):
e3000764
. .
15.
Raj
A
,
Gupta
B
,
Chowdhury
A
,
Chadha
S
.
A study of voice changes in various phases of menstrual cycle and in postmenopausal women
.
J Voice
.
2010
;
24
(
3
):
363
8
. .
16.
Arruda
P
,
Diniz da Rosa
MR
,
Almeida
LNA
,
de Araujo Pernambuco
L
,
Almeida
AA
.
Vocal acoustic and auditory-perceptual characteristics during fluctuations in estradiol levels during the menstrual cycle: a longitudinal study
.
J Voice
.
2019
;
33
(
4
):
536
44
. .
17.
Higgins
MB
,
Saxman
JH
.
Variations in vocal frequency perturbation across the menstrual cycle
.
J Voice
.
1989
;
3
:
233
43
. .
18.
Lindholm
P
,
Vilkman
E
,
Raudaskoski
T
,
Suvanto-Luukkonen
E
,
Kauppila
A
.
The effect of postmenopause and postmenopausal HRT on measured voice values and vocal symptoms
.
Maturitas
.
1997
;
28
(
1
):
47
53
. .
19.
Newman
SR
,
Butler
J
,
Hammond
EH
,
Gray
SD
.
Preliminary report on hormone receptors in the human vocal fold
.
J Voice
.
2000
;
14
(
1
):
72
81
. .
20.
Voelter
C
,
Kleinsasser
N
,
Joa
P
,
Nowack
I
,
Martínez
R
,
Hagen
R
, et al
.
Detection of hormone receptors in the human vocal fold
.
Eur Arch Otorhinolaryngol
.
2008
;
265
(
10
):
1239
44
. .
21.
Kirgezen
T
,
Sunter
AV
,
Yigit
O
,
Huq
GE
.
Sex hormone receptor expression in the human vocal fold subunits
.
J Voice
.
2017
;
31
(
4
):
476
82
. .
22.
Gerbino
G
.
The quest for the soprano voice: castrati in Renaissance Italy
.
Studi Musicali
.
2004
;
33
:
303
57
.
23.
Tatar
EC
,
Sahin
M
,
Demiral
D
,
Bayir
O
,
Saylam
G
,
Ozdek
A
, et al
.
Normative values of voice analysis parameters with respect to menstrual cycle in healthy adult Turkish women
.
J Voice
.
2016
;
30
(
3
):
322
8
. .
24.
Barillari
MR
,
Volpe
U
,
Innaro
N
,
Barillari
U
.
Is menstrual dysphonia associated with greater disability and lower quality of life
.
J Voice
.
2016
;
30
(
1
):
88
92
. .
25.
Abitbol
J
,
Abitbol
P
,
Abitbol
B
.
Sex hormones and the female voice
.
J Voice
.
1999
;
13
(
3
):
424
46
. .
26.
Shoffel-Havakuk
H
,
Carmel-Neiderman
NN
,
Halperin
D
,
Shapira Galitz
Y
,
Levin
D
,
Haimovich
Y
, et al
.
Menstrual cycle, vocal performance, and laryngeal vascular appearance: an observational study on 17 subjects
.
J Voice
.
2018
;
32
(
2
):
226
33
. .
27.
Kersing
W
,
Jennekens
FG
.
Age-related changes in human thyroarytenoid muscles: a histological and histochemical study
.
Eur Arch Otorhinolaryngol
.
2004
;
261
(
7
):
386
92
. .
28.
Akcam
T
,
Bolu
E
,
Merati
AL
,
Durmus
C
,
Gerek
M
,
Ozkaptan
Y
.
Voice changes after androgen therapy for hypogonadotrophic hypogonadism
.
Laryngoscope
.
2004
;
114
(
9
):
1587
91
. .
29.
King
A
,
Ashby
J
,
Nelson
C
.
Effects of testosterone replacement on a male professional singer
.
J Voice
.
2001
;
15
(
4
):
553
7
. .
30.
Azul
D
.
Transmasculine people’s vocal situations: a critical review of gender-related discourses and empirical data
.
Int J Lang Commun Disord
.
2015
;
50
(
1
):
31
47
. .
31.
Cler
GJ
,
McKenna
VS
,
Dahl
KL
,
Stepp
CE
.
Longitudinal case study of transgender voice changes under testosterone hormone therapy
.
J Voice
.
2020
;
34
(
5
):
748
62
. .
32.
Baker
J
.
A report on alterations to the speaking and singing voices of four women following hormonal therapy with virilizing agents
.
J Voice
.
1999
;
13
(
4
):
496
507
. .
33.
Menke
LA
,
Sas
TC
,
van Koningsbrugge
SH
,
de Ridder
MA
,
Zandwijken
GR
,
Boersma
B
, et al
.
The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome
.
J Voice
.
2011
;
25
(
5
):
602
10
. .
34.
Chadwick
KA
,
Simpson
CB
,
McGarey
PO
Jr
,
Estes
CM
,
Nix
J
,
Sulica
L
.
Voice change following testosterone supplementation in women: a multi-institutional case series
.
J Voice
.
2021
;
35
(
6
):
936.e1
7
. .
35.
Facchinetti
F
,
Unfer
V
,
Dewailly
D
,
Kamenov
ZA
,
Diamanti-Kandarakis
E
,
LaganÃ
AS
, et al
.
Inositols in polycystic ovary syndrome: an overview on the advances
.
Trends Endocrinol Metab
.
2020
;
31
(
6
):
435
47
. .
36.
Fedeli
AC
,
Querqui
A
,
Unfer
V
,
Bizzarri
M
.
Role of inositols in the hyperandrogenic phenotypes of PCOS: a Re-reading of larner’s results
.
Int J Mol Sci
.
2023
;
24
(
7
):
6296
. .
37.
Teede
HJ
,
Tay
CT
,
Laven
J
,
Dokras
A
,
Moran
L
,
Piltonen
T
, et al
.
Aya mousa, anju joham on behalf of the international PCOS network. Technical Report for the international evidence-based Guideline for the Assessment and Management of polycystic ovary syndrome
.
2023
. .
38.
Stogowska
E
,
Kamiński
KA
,
Ziółko
B
,
Kowalska
I
.
Voice changes in reproductive disorders, thyroid disorders and diabetes: a review
.
Endocr Connect
.
2022
;
11
(
3
):
e210505
. .
You do not currently have access to this content.